Bayforest Capital Ltd grew its holdings in shares of Silicon Laboratories, Inc. (NASDAQ:SLAB - Free Report) by 276.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 7,542 shares of the semiconductor company's stock after purchasing an additional 5,539 shares during the quarter. Silicon Laboratories makes up about 0.5% of Bayforest Capital Ltd's portfolio, making the stock its 23rd biggest holding. Bayforest Capital Ltd's holdings in Silicon Laboratories were worth $1,111,000 at the end of the most recent quarter.
A number of other hedge funds have also modified their holdings of SLAB. GAMMA Investing LLC grew its holdings in Silicon Laboratories by 99.6% in the 1st quarter. GAMMA Investing LLC now owns 1,126 shares of the semiconductor company's stock valued at $127,000 after buying an additional 562 shares in the last quarter. Principal Financial Group Inc. raised its stake in Silicon Laboratories by 72.2% during the first quarter. Principal Financial Group Inc. now owns 129,911 shares of the semiconductor company's stock worth $14,624,000 after purchasing an additional 54,463 shares during the period. KBC Group NV boosted its holdings in Silicon Laboratories by 27.1% in the 1st quarter. KBC Group NV now owns 1,625 shares of the semiconductor company's stock valued at $183,000 after purchasing an additional 346 shares during the last quarter. Oppenheimer Asset Management Inc. grew its stake in shares of Silicon Laboratories by 2.9% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 7,379 shares of the semiconductor company's stock valued at $831,000 after buying an additional 210 shares during the period. Finally, Wealth Enhancement Advisory Services LLC raised its position in shares of Silicon Laboratories by 9.7% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 2,334 shares of the semiconductor company's stock valued at $290,000 after buying an additional 206 shares during the period.
Wall Street Analyst Weigh In
SLAB has been the topic of a number of research analyst reports. Susquehanna lifted their target price on Silicon Laboratories from $110.00 to $150.00 and gave the company a "neutral" rating in a research report on Tuesday, July 22nd. Weiss Ratings reissued a "sell (d-)" rating on shares of Silicon Laboratories in a research report on Wednesday, October 8th. Stifel Nicolaus upped their target price on shares of Silicon Laboratories from $144.00 to $160.00 and gave the company a "buy" rating in a research report on Friday, July 18th. KeyCorp increased their target price on shares of Silicon Laboratories from $160.00 to $180.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 8th. Finally, Morgan Stanley reduced their price target on shares of Silicon Laboratories from $157.00 to $144.00 and set an "equal weight" rating on the stock in a research note on Wednesday, August 6th. Five investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, Silicon Laboratories has an average rating of "Hold" and an average target price of $151.13.
View Our Latest Stock Analysis on Silicon Laboratories
Silicon Laboratories Price Performance
SLAB stock opened at $129.05 on Tuesday. The business's 50-day moving average is $133.18 and its two-hundred day moving average is $127.09. The firm has a market capitalization of $4.23 billion, a P/E ratio of -40.08 and a beta of 1.51. Silicon Laboratories, Inc. has a 1 year low of $82.82 and a 1 year high of $160.00.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The semiconductor company reported $0.11 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.09 by $0.02. Silicon Laboratories had a negative net margin of 14.88% and a negative return on equity of 7.21%. The company had revenue of $192.85 million during the quarter, compared to the consensus estimate of $192.57 million. During the same quarter in the previous year, the firm earned ($0.56) earnings per share. The firm's quarterly revenue was up 32.6% on a year-over-year basis. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS. On average, analysts expect that Silicon Laboratories, Inc. will post -0.97 EPS for the current year.
Insider Activity
In related news, SVP Brandon Tolany sold 8,000 shares of the business's stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $145.23, for a total transaction of $1,161,840.00. Following the completion of the sale, the senior vice president owned 62,328 shares in the company, valued at $9,051,895.44. The trade was a 11.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Over the last ninety days, insiders sold 12,070 shares of company stock worth $1,703,472. Corporate insiders own 1.60% of the company's stock.
About Silicon Laboratories
(
Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Further Reading
Want to see what other hedge funds are holding SLAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Silicon Laboratories, Inc. (NASDAQ:SLAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report